In addition, Israeli researchers and collaborating teams have demonstrated the safety and efficacy of CD24-loaded EVs in >180 patients with COVID-19-associated ARDS in phase 1b/2a, phase 2b, and compassionate use (NCT04747574, NCT04902183, and NCT05947747)103,189,190. The gene discussed is CD24; the disease is acute respiratory distress syndrome.